BLIS Technologies Limited logo

Third quarter performance update

Guidance16 February 2023BLTConsumer Staples

17 February 2023
Third Quarter Performance Update

Blis Technologies Limited (Blis) delivers revenue growth of 24% and a positive EBITDA

result for the third quarter ending 31 Dec 2022 (unaudited).

Revenue for the quarter

[1]

was $2.9m, an increase of $0.6m compared with the same

period last year

[2]

. EBITDA profit for the quarter

[1]

was $0.3m.

“The continued recovery of our European ingredient business has seen sales volumes

return to the pre-covid levels of FY20. Revenue growth is also being delivered in the

New Zealand based retail channel (incl Daigou) and online sales through Amazon USA.

This growth along with refocused market investment has returned us to a path for

sustainable profitability, with a positive EBITDA forecast for the second half year.” said

Brian Watson CEO.

Revenue for the nine months to 31 December 2022 was $7.2m up 15% on the same

period last year, EBITDA loss for this same nine month period is $0.9m, which includes

one off costs associated with the strategy reset of $0.3. This is a solid improvement on

the $1.9m EBITDA loss in the same period last year.

Based on our latest customer sales forecasts and market feedback, guidance is for full

year revenue to be between $9.5m and $9.8m, with an EBITDA deficit in the range of

$1.0m to $1.2m.

[1]

The three months ended 31 December 2022

[2]

The three months ended 31 December 2021

Ends


For further information, please contact:


Brian Watson

CEO

+64 27 705 9133


About Blis Technologies Ltd


Delivering proven health benefits through evidence-based, advanced probiotics

Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut.

Combining innovation with evidence-based research and the highest quality production controls enables

the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath),

immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand

and in Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at

www.blis.co.nz.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.